AstraZeneca PLC closed 24.31% short of its 52-week high of £133.88, which the company reached on September 3rd.

AstraZeneca PLC closed 21.54% below its 52-week high of £133.88, which the company reached on September 3rd.

In the expense commentary above, the plus and minus bullets denote the directional impact of the item being discussed, e.g. a '+' symbol beside ... allegations, AstraZeneca received an Appraisal ...

On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials assessed the efficacy and safety of ...

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) reported Tuesday that its first-quarter profit climbed from last year on sales growth. Further, the company reitereated its fiscal 2025 ...

May 2 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma ...

CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company said it ...

Guidance AstraZeneca reiterates its Total Revenue and Core EPS guidance 5 for FY 2025 at CER, based on the average foreign exchange rates through 2024.